PAPA (Papa Medical) Forward PE Ratio: 0.00 (As of Jul. 11, 2026)


What is Papa Medical Forward PE Ratio?

Papa Medical PAPA Forward PE Ratio is 0.00 as of Jul. 11, 2026.

Papa Medical's Forward PE Ratio for today is 0.00.

Papa Medical's PE Ratio without NRI for today is 0.00.

Papa Medical's PE Ratio (TTM) for today is 0.00.

Papa Medical  (NAS:PAPA) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Papa Medical Forward PE Ratio Related Terms

Papa Medical Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Papa Medical's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Papa Medical Forward PE Ratio Chart

Papa Medical Annual Data
Trend
Forward PE Ratio

Papa Medical Quarterly Data
Forward PE Ratio

PAPA vs : Forward PE Ratio Comparison

For the Tobacco subindustry, Papa Medical's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Papa Medical Forward PE Ratio vs Tobacco Products Industry

For the Tobacco Products industry and Consumer Defensive sector, Papa Medical's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Papa Medical's Forward PE Ratio falls into.


Papa Medical Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 0.00 mean?
Papa Medical (PAPA) has a Forward PE Ratio of 0.00 as of Jul. 11, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Papa Medical and its competitors.
Is Papa Medical's Forward PE Ratio too high?
Papa Medical's current Forward PE Ratio is 0.00.
How does Papa Medical's Forward PE Ratio compare to ?
Papa Medical's Forward PE Ratio of 0.00 can be compared against companies in the Tobacco Products industry. The industry median Forward PE Ratio is 12.14. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Tobacco Products company?
The median Forward PE Ratio among Tobacco Products companies is 12.14, based on 24 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Papa Medical and its competitors. For the Tobacco Products industry, the median Forward PE Ratio is 12.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Papa Medical's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Papa Medical stock overvalued right now?
Papa Medical (PAPA) has a current Forward PE Ratio of 0.00. The current Forward PE Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Papa Medical (PAPA), the current Forward PE Ratio is 0.00 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Papa Medical Business Description

Comparable Companies
Address 202 North California Ave, City of Industry, CA, USA, 91744
Papa Medical Inc is the first end-to-end cannabis dosing solution provider in the U.S. that possesses the medical atomization or nebulizing background and sells nebulizers. The company deeply engages in key activities in the cannabis and consuming E-vapors industry, from research and development, formulation design, e-liquid production, and e-liquid filling to e-liquid co-packing services. It is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis E-vapors.